EGFR and breast carcinoma: In addition, IGFBP-3 plays a role in the DNA repair response to DNA-damaging therapy and was shown to co-translocate to the nucleus of breast cancer cells with EGFR and DNA-dependent protein kinase in response to DNA damage, to mediate this function [64,65].